Section 4 Plastic and Reconstructive Problems

TR I NDADE DE ALME I DA ET AL

91. Hexsel D, Zechmeister M, Zechmeister D, Dal’Forno T. Assessing botulinum toxin diffusion. In: Almeida ART, Hexsel DM, editors. Hyperhidrosis and Botulinum Toxin, Vol. 23. Edition of authors. S a˜ o Paulo, 2004. p. 133–40. 92. Hexsel DM, Soirefmann M, Rodrigues TC, do Prado DZ. In- creasing the field effects of similar doses of Clostridium botulinum type A toxin-hemagglutinin complex in the treatment of com- pensatory hyperhidrosis. Arch Dermatol 2009;145:837–40. Address correspondence and reprint requests to: Ada R. Trindade de Almeida, MD, Clı´nica Dermatolo´ gica do Hospital do Servidor Pu´ blico Municipal de Sa˜o Paulo, Sa˜o Paulo, Brazil. Rua Fa´bia, 94 apto.111A, Vila Romana, Sa˜o Paulo, Sa˜o Paulo 05051-030, Brazil, or e-mail: artrindal@ uol.com.br

in children with cerebral palsy: a randomized trial comparing two injection volumes. Clin Rehabil 2009;23:64–71.

86. Grunfeld A, Murray C, Solish N. Botulinum toxin for hyperhidrosis: a review. Am J Clin Dermatol 2009;10:87–102. 87. Kreyden O. Botulinum toxin in the management of focal hyperhidrosis. In: Benedetto A, editor. Botulinum Toxin in Clinical Dermatology, Vol. 10. London: Taylor and Francis; 2006. p. 278–9. 88. Glaser D, Hebert A, Pariser D, Solish N. Facial hyperhidrosis: best practice recommendations and special considerations. Cutis 2007;79(suppl 5):29–32. 89. Talarico Filho S, Nascimento M, Macedo F, Pe´cora C. A double- blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg 2007;33:S44–50.

90. Dressler D. Comparing botox and xeomin for axillar hype- rhidrosis. J Neural Transm 2010;117:317–9.

3 7 : 1 1 : NOVEMBER 2 0 1 1